tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

SHPH Stock Latest News

Shuttle reaches milestone in enrollment for Phase 2 trial of Ropidoxuridine
The FlyShuttle reaches milestone in enrollment for Phase 2 trial of Ropidoxuridine
10d ago
SHPH
Shuttle Pharmaceuticals enters into sponsored research agreement with UCSF
PremiumThe Fly
Shuttle Pharmaceuticals enters into sponsored research agreement with UCSF
1M ago
SHPH
Shuttle Pharmaceuticals Starts Phase 2 Trial for Glioblastoma
PremiumCompany Announcements
Shuttle Pharmaceuticals Starts Phase 2 Trial for Glioblastoma
2M ago
8K
SHPH
Shuttle first patient enrollment, dosing in Phase 2 Ropidoxuridine line
PremiumThe Fly
Shuttle first patient enrollment, dosing in Phase 2 Ropidoxuridine line
2M ago
SHPH
Shuttle Pharma Raises $4.5M for Clinical Trials
PremiumCompany Announcements
Shuttle Pharma Raises $4.5M for Clinical Trials
3M ago
8K
SHPH
3 Penny Stocks to Watch Now, 10/31/24
PremiumMarket News3 Penny Stocks to Watch Now, 10/31/24
3M ago
BKYI
SHPH
Shuttle Pharmaceuticals prices $4.5M at-the-market offering at $1.525 per share
Premium
The Fly
Shuttle Pharmaceuticals prices $4.5M at-the-market offering at $1.525 per share
3M ago
SHPH
Shuttle Pharmaceuticals Advances Phase 2 Glioblastoma Trial
Premium
Company Announcements
Shuttle Pharmaceuticals Advances Phase 2 Glioblastoma Trial
3M ago
8K
SHPH
Shuttle Pharmaceuticals doses first patients in Phase 2 trial of Ropidoxuridine
PremiumThe Fly
Shuttle Pharmaceuticals doses first patients in Phase 2 trial of Ropidoxuridine
3M ago
SHPH
Shuttle Pharmaceuticals Advances Glioblastoma Clinical Trials
PremiumCompany Announcements
Shuttle Pharmaceuticals Advances Glioblastoma Clinical Trials
3M ago
8K
SHPH
Shuttle’s clinical trial site enrollments complete for Phase 2 of IPdR for GBM
PremiumThe Fly
Shuttle’s clinical trial site enrollments complete for Phase 2 of IPdR for GBM
3M ago
SHPH
Shuttle Pharmaceuticals to Present at ThinkEquity Conference
PremiumCompany Announcements
Shuttle Pharmaceuticals to Present at ThinkEquity Conference
3M ago
8K
SHPH
Shuttle Pharmaceuticals files to sell common stock, warrants, no amount given
PremiumThe FlyShuttle Pharmaceuticals files to sell common stock, warrants, no amount given
4M ago
SHPH
Shuttle Pharmaceuticals expands clinical trial site enrollment for Phase 2 trial
Premium
The Fly
Shuttle Pharmaceuticals expands clinical trial site enrollment for Phase 2 trial
5M ago
SHPH
Shuttle Pharmaceuticals announces issuance of U.S. patent HDAC inhibitors
Premium
The Fly
Shuttle Pharmaceuticals announces issuance of U.S. patent HDAC inhibitors
5M ago
SHPH
Shuttle Pharmaceuticals gets ODD for IPdR to treat brain tumors
PremiumThe Fly
Shuttle Pharmaceuticals gets ODD for IPdR to treat brain tumors
5M ago
SHPH
Shuttle Pharmaceuticals regains compliance with Nasdaq requirement
PremiumThe Fly
Shuttle Pharmaceuticals regains compliance with Nasdaq requirement
5M ago
SHPH
Shuttle Pharmaceuticals receives noncompliance notification from Nasdaq
PremiumThe Fly
Shuttle Pharmaceuticals receives noncompliance notification from Nasdaq
5M ago
SHPH
Shuttle Pharmaceuticals opens enrollment in Ropidoxuridine trial
PremiumThe Fly
Shuttle Pharmaceuticals opens enrollment in Ropidoxuridine trial
6M ago
SHPH
Shuttle Pharmaceuticals Holdings Inc trading halted, news pending
PremiumThe FlyShuttle Pharmaceuticals Holdings Inc trading halted, news pending
6M ago
SHPH
Shuttle Pharmaceuticals announces publication of manuscript on SP-1-303
Premium
The Fly
Shuttle Pharmaceuticals announces publication of manuscript on SP-1-303
7M ago
SHPH
Shuttle Pharmaceuticals Welcomes New CFO Timothy Lorber
Premium
Company Announcements
Shuttle Pharmaceuticals Welcomes New CFO Timothy Lorber
8M ago
8K
SHPH

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >